Chimeric yellowish fever/dengue virus as an applicant dengue vaccine: quantitation from the dengue virus-specific Compact disc8 T-cell response
Chimeric yellowish fever/dengue virus as an applicant dengue vaccine: quantitation from the dengue virus-specific Compact disc8 T-cell response. following the excellent immunization led to improved neutralizing antibodies which were suffered for at least 30 weeks. Immunization at a variety of dosages of DENV2 VRP shielded mice from an otherwise-lethal intracranial DENV2 problem. To model vaccination…